AIM Vaccine Management

Management criteria checks 3/4

AIM Vaccine's CEO is Yan Zhou, appointed in Sep 2020, has a tenure of 4.67 years. total yearly compensation is CN¥2.19M, comprised of 86.3% salary and 13.7% bonuses, including company stock and options. directly owns 16.41% of the company’s shares, worth HK$714.71M. The average tenure of the management team and the board of directors is 4.2 years and 4.9 years respectively.

Key information

Yan Zhou

Chief executive officer

CN¥2.2m

Total compensation

CEO salary percentage86.3%
CEO tenure4.7yrs
CEO ownership16.4%
Management average tenure4.2yrs
Board average tenure4.9yrs

Recent management updates

Recent updates

Take Care Before Jumping Onto AIM Vaccine Co., Ltd. (HKG:6660) Even Though It's 25% Cheaper

Apr 04
Take Care Before Jumping Onto AIM Vaccine Co., Ltd. (HKG:6660) Even Though It's 25% Cheaper

Here's Why AIM Vaccine (HKG:6660) Can Afford Some Debt

Nov 15
Here's Why AIM Vaccine (HKG:6660) Can Afford Some Debt

Why Investors Shouldn't Be Surprised By AIM Vaccine Co., Ltd.'s (HKG:6660) 27% Share Price Plunge

Aug 24
Why Investors Shouldn't Be Surprised By AIM Vaccine Co., Ltd.'s (HKG:6660) 27% Share Price Plunge

It's A Story Of Risk Vs Reward With AIM Vaccine Co., Ltd. (HKG:6660)

May 29
It's A Story Of Risk Vs Reward With AIM Vaccine Co., Ltd. (HKG:6660)

Investor Optimism Abounds AIM Vaccine Co., Ltd. (HKG:6660) But Growth Is Lacking

Jun 09
Investor Optimism Abounds AIM Vaccine Co., Ltd. (HKG:6660) But Growth Is Lacking

CEO Compensation Analysis

How has Yan Zhou's remuneration changed compared to AIM Vaccine's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024CN¥2mCN¥2m

-CN¥277m

Sep 30 2024n/an/a

-CN¥734m

Jun 30 2024n/an/a

-CN¥1b

Mar 31 2024n/an/a

-CN¥1b

Dec 31 2023CN¥2mCN¥2m

-CN¥1b

Sep 30 2023n/an/a

-CN¥913m

Jun 30 2023n/an/a

-CN¥525m

Mar 31 2023n/an/a

-CN¥422m

Dec 31 2022CN¥2mCN¥2m

-CN¥320m

Dec 31 2021CN¥899mCN¥1m

-CN¥693m

Compensation vs Market: Yan's total compensation ($USD303.66K) is about average for companies of similar size in the Hong Kong market ($USD423.85K).

Compensation vs Earnings: Yan's compensation has increased whilst the company is unprofitable.


CEO

Yan Zhou (57 yo)

4.7yrs

Tenure

CN¥2,194,000

Compensation

Mr. Yan Zhou is Executive Chairman and Chief Executive Officer of AIM Vaccine Co., Ltd. September 2020. He has served as a Director of AIM Vaccine Co., Ltd.since May 2015 and was re-designated as an execu...


Leadership Team

NamePositionTenureCompensationOwnership
Yan Zhou
Executive Chairman & CEO4.7yrsCN¥2.19m16.41%
HK$ 714.7m
Xin Zhou
Executive Vice-Chairman & Executive President12yrsCN¥896.00k3.26%
HK$ 142.0m
Jie Zhou
Executive Director & Executive Presidentless than a yearCN¥808.00k3.26%
HK$ 142.0m
Wen Guan
Executive President & Executive Director4.3yrsCN¥2.24mno data
Shaojun Jia
President & Executive Director4.3yrsCN¥2.27m0.83%
HK$ 36.1m
Lixin Niu
Chief Financial Officer9.6yrsno datano data
Ling Liu
Secretary & Chief Investment Officer9.5yrsno datano data
Fan Zhang
Chief Research Officer4.2yrsno datano data
Li Meng
Chief Quality Officer3.1yrsno datano data
Wenjuan Zhou
Chief Public Affairs Officer3.2yrsno datano data
Wing Chi Lam
Joint Company Secretary3.9yrsno datano data

4.2yrs

Average Tenure

55yo

Average Age

Experienced Management: 6660's management team is considered experienced (4.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Yan Zhou
Executive Chairman & CEO10yrsCN¥2.19m16.41%
HK$ 714.7m
Xin Zhou
Executive Vice-Chairman & Executive President12yrsCN¥896.00k3.26%
HK$ 142.0m
Jie Zhou
Executive Director & Executive President10yrsCN¥808.00k3.26%
HK$ 142.0m
Wen Guan
Executive President & Executive Director4.3yrsCN¥2.24mno data
Shaojun Jia
President & Executive Director7.8yrsCN¥2.27m0.83%
HK$ 36.1m
Ker Wei Pei
Independent Non-Executive Director4.7yrsCN¥300.00kno data
Tingfeng Song
Chairman of The Supervisory Committee4.3yrsno datano data
Xiaoguang Guo
Independent Non-Executive Director4.3yrsCN¥300.00kno data
Jichen Zhao
Non-Executive Director4.9yrsno datano data
Jie Wen
Independent Non-Executive Director4yrsCN¥300.00kno data
Lun Ma
Supervisor9.4yrsno datano data
Jiashuai Song
Employee Representative Supervisor4.9yrsno datano data

4.9yrs

Average Tenure

58yo

Average Age

Experienced Board: 6660's board of directors are considered experienced (4.9 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/07 00:13
End of Day Share Price 2025/05/07 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AIM Vaccine Co., Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullFosun International Securities Limited
Tony RenMacquarie Research